RUNX1 positively regulates a cell adhesion and migration program in murine hemogenic endothelium prior to blood emergence
- PMID: 25082880
- DOI: 10.1182/blood-2014-04-572958
RUNX1 positively regulates a cell adhesion and migration program in murine hemogenic endothelium prior to blood emergence
Abstract
During ontogeny, the transcription factor RUNX1 governs the emergence of definitive hematopoietic cells from specialized endothelial cells called hemogenic endothelium (HE). The ultimate consequence of this endothelial-to-hematopoietic transition is the concomitant activation of the hematopoietic program and downregulation of the endothelial program. However, due to the rare and transient nature of the HE, little is known about the initial role of RUNX1 within this population. We, therefore, developed and implemented a highly sensitive DNA adenine methyltransferase identification-based methodology, including a novel data analysis pipeline, to map early RUNX1 transcriptional targets in HE cells. This novel transcription factor binding site identification protocol should be widely applicable to other low abundance cell types and factors. Integration of the RUNX1 binding profile with gene expression data revealed an unexpected early role for RUNX1 as a positive regulator of cell adhesion- and migration-associated genes within the HE. This suggests that RUNX1 orchestrates HE cell positioning and integration prior to the release of hematopoietic cells. Overall, our genome-wide analysis of the RUNX1 binding and transcriptional profile in the HE provides a novel comprehensive resource of target genes that will facilitate the precise dissection of the role of RUNX1 in early blood development.
© 2014 by The American Society of Hematology.
Similar articles
-
Runx1 is sufficient for blood cell formation from non-hemogenic endothelial cells in vivo only during early embryogenesis.Development. 2018 Jan 29;145(2):dev158162. doi: 10.1242/dev.158162. Development. 2018. PMID: 29361566 Free PMC article.
-
The Role of Runx1 in Embryonic Blood Cell Formation.Adv Exp Med Biol. 2017;962:47-64. doi: 10.1007/978-981-10-3233-2_4. Adv Exp Med Biol. 2017. PMID: 28299650 Free PMC article. Review.
-
Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.Development. 2018 Mar 12;145(5):dev149419. doi: 10.1242/dev.149419. Development. 2018. PMID: 29530939 Free PMC article.
-
Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac.Development. 2016 Dec 1;143(23):4341-4351. doi: 10.1242/dev.140970. Epub 2016 Oct 17. Development. 2016. PMID: 27802172
-
Taking the Leap: Runx1 in the Formation of Blood from Endothelium.Curr Top Dev Biol. 2016;118:113-62. doi: 10.1016/bs.ctdb.2016.01.008. Epub 2016 Feb 18. Curr Top Dev Biol. 2016. PMID: 27137656 Review.
Cited by
-
Overexpression of the Hsa21 Transcription Factor RUNX1 Modulates the Extracellular Matrix in Trisomy 21 Cells.Front Genet. 2022 Mar 10;13:824922. doi: 10.3389/fgene.2022.824922. eCollection 2022. Front Genet. 2022. PMID: 35356434 Free PMC article.
-
Tuning apicobasal polarity and junctional recycling in the hemogenic endothelium orchestrates the morphodynamic complexity of emerging pre-hematopoietic stem cells.Elife. 2024 May 29;12:RP91429. doi: 10.7554/eLife.91429. Elife. 2024. PMID: 38809590 Free PMC article.
-
GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1.Nat Cell Biol. 2016 Jan;18(1):21-32. doi: 10.1038/ncb3276. Epub 2015 Nov 30. Nat Cell Biol. 2016. PMID: 26619147
-
RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.Oncotarget. 2016 Feb 9;7(6):6552-65. doi: 10.18632/oncotarget.6771. Oncotarget. 2016. PMID: 26735887 Free PMC article.
-
New insights into the regulation by RUNX1 and GFI1(s) proteins of the endothelial to hematopoietic transition generating primordial hematopoietic cells.Cell Cycle. 2016 Aug 17;15(16):2108-2114. doi: 10.1080/15384101.2016.1203491. Epub 2016 Jul 11. Cell Cycle. 2016. PMID: 27399214 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 15675/CRUK_/Cancer Research UK/United Kingdom
- 12487/CRUK_/Cancer Research UK/United Kingdom
- BB/F000499/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- 12486/CRUK_/Cancer Research UK/United Kingdom
- BB/I001794/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources

